{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T20:20:21Z","timestamp":1781554821359,"version":"3.54.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,7,13]],"date-time":"2007-07-13T00:00:00Z","timestamp":1184284800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2007,9,21]]},"DOI":"10.1007\/s12016-007-0002-2","type":"journal-article","created":{"date-parts":[[2007,7,16]],"date-time":"2007-07-16T21:07:36Z","timestamp":1184620056000},"page":"192-197","source":"Crossref","is-referenced-by-count":24,"title":["Looking Into the Eyes of Patients with Antiphospholipid Syndrome"],"prefix":"10.1007","volume":"32","author":[{"given":"D.","family":"Yehudai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Shoenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Toubi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,7,13]]},"reference":[{"key":"2_CR1","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1191\/0961203303lu396xx","volume":"12","author":"Y Shoenfeld","year":"2003","unstructured":"Shoenfeld Y (2003) Systemic antiphospholipid syndrome. Lupus 12:497\u2013498","journal-title":"Lupus"},{"key":"2_CR2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1076\/ocii.9.1.49.3980","volume":"9","author":"D Giorgi","year":"2001","unstructured":"Giorgi D, David V, Afeltra A, Gabrieli CB (2001) Transient visual symptoms in systemic lupus erythematosus and antiphospholipid syndrome. Ocul Immunol Inflamm 9:49\u201357","journal-title":"Ocul Immunol Inflamm"},{"key":"2_CR3","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/ard.48.5.358","volume":"48","author":"RA Asherson","year":"1989","unstructured":"Asherson RA, Merry P, Acheson JF, Harris EN, Hughes GR (1989) Antiphospholipid antibodies: a risk factor for occlusive ocular vascular disease in SLE and primary antiphospholipid syndrome. Ann Rheum Dis 48:358\u2013361","journal-title":"Ann Rheum Dis"},{"key":"2_CR4","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0161-6420(95)31028-7","volume":"102","author":"C Castanon","year":"1995","unstructured":"Castanon C, Amigo MC, Banales JL, Nava A, Reyes PA (1995) Ocular vaso-occlusive disease in primary antiphospholipid syndrome. Ophthalmology 102:256\u2013262","journal-title":"Ophthalmology"},{"key":"2_CR5","first-page":"2437","volume":"28","author":"J Carbone","year":"2001","unstructured":"Carbone J, Sanchez-Ramon S, Cobo-Soriano R, Seoane E, Aparicio MJ, Ruiz-Tiscar JL et al (2001) Antiphospholipid antibodies: a risk factor for occlusive retinal vascular disorders. Comparison with ocular inflammatory diseases. J Rheumatol 28:2437\u20132441","journal-title":"J Rheumatol"},{"key":"2_CR6","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0039-6257(02)00289-8","volume":"47","author":"OM Durrani","year":"2002","unstructured":"Durrani OM, Gordon C, Murray PI (2002) Primary anti-phospholipid syndrome: current concepts. Surv Ophthalmol 47:215\u2013238.","journal-title":"Surv Ophthalmol"},{"key":"2_CR7","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1177\/096120339700600712","volume":"6","author":"D Giorgi","year":"1997","unstructured":"Giorgi D, Vaccaro F (1997) Vaso-occlusive retinopathy: is it a classical clinical manifestation of the APS. Lupus 6:617","journal-title":"Lupus"},{"key":"2_CR8","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S0002-9394(14)72731-X","volume":"120","author":"CM Greven","year":"1995","unstructured":"Greven CM, Slusher MM, Weaver RG (1995) Retinal artery occlusion in young adults. Am J Ophthalmol 120:776\u2013783","journal-title":"Am J Ophthalmol"},{"key":"2_CR9","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1023\/A:1006305705080","volume":"22","author":"FY Demirci","year":"1998","unstructured":"Demirci FY, Kucukkaya R, Akarcay K, Kir N, Atamer T, Demirci H, Ongor E (1998) Ocular involvement in APS. Int Ophthalmol 22:323\u2013329","journal-title":"Int Ophthalmol"},{"key":"2_CR10","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/S0161-6420(99)90450-5","volume":"106","author":"YA Gelfand","year":"1999","unstructured":"Gelfand YA, Dori D, Miller B, Brenner B (1999) Visual disturbances and pathologic ocular findings in primary antiphospholoipid syndrome. Ophthalmology 106:1537\u20131540","journal-title":"Ophthalmology"},{"key":"2_CR11","first-page":"1344","volume":"31","author":"Y Shoenfeld","year":"2004","unstructured":"Shoenfeld Y, Lev S, Blatt I, Blank M, Font J, von Landenberg P et al (2004) Features associated with epilepsy in the antiphospholipid syndrome. J Rheumatol 31:1344\u20131348","journal-title":"J Rheumatol"},{"key":"2_CR12","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0002-9394(99)00311-6","volume":"128","author":"R Cobo-Soriano","year":"1999","unstructured":"Cobo-Soriano R, Sanchez-Ramon S, Aparicio MJ, Teijero MA, Vidal P, Suarez-Leoz M et al (1999) Antiphospholipid antibodies and retinal thrombosis in patients without risk factors. Am J Ophthalmol 128:725\u2013732","journal-title":"Am J Ophthalmol"},{"key":"2_CR13","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1023\/A:1001131323739","volume":"95","author":"CD Kalogeropoulos","year":"1998","unstructured":"Kalogeropoulos CD, Spyron P, Stefanioton MI, Tsironi EE, Drosos AA, Psilas KG (1998) Anticardiolipin antibodies and occlusive vascular disease of the eye: prospective study. Doc Ophthalmol 95:109\u2013120","journal-title":"Doc Ophthalmol"},{"key":"2_CR14","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/00006982-200308000-00007","volume":"23","author":"ZF Bashshur","year":"2003","unstructured":"Bashshur ZF, Taher A, Masri AF, Najjar D, Arayssi TK, Noureddin BN (2003) Anticardiolipin antibodies in patients with retinal vein occlusion and no risk factors: a prospective study. Retina 23:486\u2013490","journal-title":"Retina"},{"key":"2_CR15","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1034\/j.1600-0420.1999.770604.x","volume":"77","author":"O Tekeli","year":"1999","unstructured":"Tekeli O, Gursel E, Buyurgan H (1999) Protein C, protein S, and anti-thrombin III deficiencies in retinal vein occlusion. Acta Ophthalmol Scand 77:628\u2013630","journal-title":"Acta Ophthalmol Scand"},{"key":"2_CR16","first-page":"131","volume":"12","author":"C Incorvaia","year":"2002","unstructured":"Incorvaia C, Bandello F, Parmeggiani F, D\u2019Angelo S, Costagliola C, Sebastiani A (2002) Recurrent central retinal vein occlusion in a young thrombophilic patient with factor V Leiden mutation. Eur J Ophthalmol 12:131\u2013134","journal-title":"Eur J Ophthalmol"},{"key":"2_CR17","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.thromres.2005.03.005","volume":"117","author":"M Paccalin","year":"2006","unstructured":"Paccalin M, Manic H, Bouche G, Landron C, Mercie M, Boinot C et al (2006) Antiphospholipid syndrome in patients with retinal venous occlusion. Thromb Res 117:365\u2013369","journal-title":"Thromb Res"},{"key":"2_CR18","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1034\/j.1600-0420.1998.760412.x","volume":"76","author":"J Larsson","year":"1998","unstructured":"Larsson J, Bauer B, Cavallin-Sjoberg U, Andersson S (1998) Fluorescein angiography vs ERG for predicting the prognosis in central vein occlusion. Acta Ophthalmol Scand 76:456\u2013460","journal-title":"Acta Ophthalmol Scand"},{"key":"2_CR19","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/00006982-200603000-00007","volume":"26","author":"C Hvarfner","year":"2006","unstructured":"Hvarfner C, Andreasson S, Larsson J (2006) Multifocal electroretinography and fluorescein angiography in retinal vein occlusion. Retina 26:292\u2013296","journal-title":"Retina"},{"key":"2_CR20","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0009-9260(96)80159-0","volume":"51","author":"GM Baxter","year":"1996","unstructured":"Baxter GM, Williamson TH (1996) The value of serial Doppler imaging in central retinal vein occlusion: correlation with visual recovery. Clin Radiol 51:411\u2013414","journal-title":"Clin Radiol"},{"key":"2_CR21","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1136\/bjo.86.11.1243","volume":"86","author":"S Arsene","year":"2002","unstructured":"Arsene S, Giraudeau B, Le Lez ML, Pisella PJ, Pourcelot L, Tranquart F (2002) Follow-up by colour Doppler imaging of 102 patients with retinal vein occlusion over 1\u00a0year. Br J Ophthalmol 86:1243\u20131247","journal-title":"Br J Ophthalmol"},{"key":"2_CR22","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0198-8859(99)00035-X","volume":"60","author":"D Giorgi","year":"1999","unstructured":"Giorgi D, Pace F, Giorgi A, Bonomo L, Gabrieli CB (1999) Retinopathy in SLE: pathogenesis and approach to therapy. Hum Immunol 60:688\u2013696","journal-title":"Hum Immunol"},{"key":"2_CR23","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1442-9071.2004.00766.x","volume":"32","author":"A Au","year":"2004","unstructured":"Au A, O\u2019Day J (2004) Review of severe vaso-active retinopathy in systemic lupus erythematosus and the antiphospholipid syndrome: associations, visual outcomes, complications and treatment. Clin Exp Ophthalmol 32:87\u2013100","journal-title":"Clin Exp Ophthalmol"},{"key":"2_CR24","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/eye.2000.79","volume":"14","author":"D Kent","year":"2000","unstructured":"Kent D, Hickey-Dwyer M, Clark D (2000) Long-term follow-up of ischemic retinopathy in the antiphospholipid syndrome. Eye 14:313\u2013317","journal-title":"Eye"},{"key":"2_CR25","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00006982-200603000-00006","volume":"26","author":"P Mruthyunjaya","year":"2006","unstructured":"Mruthyunjaya P, Wirostko WJ, Chandrashekhar R, Stinnet S, Lai JC, Deramo V et al (2006) Central retinal vein occlusion in patients treated with long-term warfarin sodium (coumadin) for anticoagulation. Retina 26:285\u2013291","journal-title":"Retina"},{"key":"2_CR26","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.ophtha.2003.09.047","volume":"111","author":"DJ Browning","year":"2004","unstructured":"Browning DJ, Fraser CM (2004) Retinal vein occlusions in patients taking warfarin. Ophthalmology 111:1196\u20131200","journal-title":"Ophthalmology"},{"key":"2_CR27","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1538-7836.2005.01340.x","volume":"3","author":"G Finazzi","year":"2005","unstructured":"Finazzi G, Marchioli R, Brancaccio V, Schinco P, Wisloff F, Musial J et al (2005) A randomized clinical trial of high-intensity warfarin vs conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with antiphosphlipid syndrome. J Thromb Haemost 3:848\u2013853","journal-title":"J Thromb Haemost"},{"key":"2_CR28","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1136\/bjo.84.6.609","volume":"84","author":"A Glacet-Bernard","year":"2000","unstructured":"Glacet-Bernard A, Kuhn D, Vine AK, Oubraham H, Coscas G, Soubrane G (2000) Treatment of recent onset central retinal vein occlusion with intravitreal tissue plasminogen activator: a pilot study. Br J Ophthalmol 84:609\u2013613","journal-title":"Br J Ophthalmol"},{"key":"2_CR29","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1001\/archopht.122.7.987","volume":"122","author":"N Maar","year":"2004","unstructured":"Maar N, Luksch A, Graebe A, Ergun E, Wimpissinger B, Tittl M et al (2004) Effect of laser photocoagulation on the retinal vessel diameter in branch and macular vein occlusion. Arch Ophthalmol 122:987\u2013991","journal-title":"Arch Ophthalmol"},{"key":"2_CR30","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/00006982-200510000-00006","volume":"25","author":"O Cekic","year":"2005","unstructured":"Cekic O, Chang S, Tseng JJ, Barile GR, Del Priore LV, Weissman H et al (2005) Intravitreal triamcinolone injection for treatment of macular edema secondary to branch retinal vein occlusion. Retina 25:851\u2013855","journal-title":"Retina"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-007-0002-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-007-0002-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-007-0002-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T21:48:37Z","timestamp":1559425717000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-007-0002-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7,13]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,9,21]]}},"alternative-id":["2"],"URL":"https:\/\/doi.org\/10.1007\/s12016-007-0002-2","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,7,13]]}}}